20
Views
2
CrossRef citations to date
0
Altmetric
Perspective

Ablation should not be first-line therapy for the treatment of atrial fibrillation

Pages 673-679 | Published online: 10 Jan 2014

References

  • Verma A, Natale A. Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation should be considered first-line therapy for some patients. Circulation112(8), 1214–1222 (2005).
  • Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation114(7), e257–e354 (2006).
  • Padanilam BJ, Prystowsky EN. Should atrial fibrillation ablation be considered first-line therapy for some patients? Should ablation be first-line therapy and for whom? The antagonist position. Circulation112(8), 1223–1229 (2005).
  • Boden WE, O’Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. N. Engl. J. Med.356, 1503–1516 (2007).
  • Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L; SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N. Engl. J. Med.356, 1009–1019 (2007).
  • Calkins H. Catheter ablation should not be first-line therapy for atrial fibrillation. Nat. Clin. Pract. Cardiovasc. Med.4(1), 4–5 (2007).
  • Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA285, 2864–2870 (2001).
  • Oral A, Chugh M, Ozyadin E et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation for atrial fibrillation. Circulation114, 759–765 (2006).
  • Sherman DG. Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control. Stroke38, 615–617 (2007).
  • Hindricks G, Piorkowski C, Tanner H et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation112(3), 307–313 (2005).
  • Haissaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med.339, 659–666 (1998).
  • Pappone C, Rosanio S, Augello G et al. Mortality, morbidity and quality of life after circumferential pulmonary vein ablation for atrial fibrillation. J. Am. Coll. Cardiol.42, 185–197 (2003).
  • Fuster V, Ryden LE, Asinger RW et al. Guidelines for the management of patients with atrial fibrillation. Circulation104(17), 2118–2150 (2001).
  • Alboni P, Botto GL, Baldi N et al. Outpatient treatment of recent-onset atrial fibrillation with the “pill-in-the-pocket” approach. N. Engl. J. Med.351(23), 2384–2391 (2004).
  • Cappato R, Calkins H, Chen SA et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation111(9), 1100–1105 (2005).
  • Doll N, Borger MA, Fabricius A et al. Esophageal perforation during left atrial radiofrequency ablation: is the risk too high? J. Thorac. Cardiovasc. Surg.125(4), 836–842 (2003).
  • Pappone C, Oral H, Santinelli V et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation109(22), 2724–2726 (2004).
  • Dixit S, Marchlinski FE. How to recognize, manage, and prevent complications during atrial fibrillation ablation. Heart Rhythm4, 108–115 (2007).
  • Lickfett L, Hackenbroch M, Lewalter T et al. Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. J. Cardiovasc. Electrophysiol.17, 1–7 (2006).
  • Pappone C, Augello G, Sala S et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J. Am. Coll. Cardiol.48(11), 2340–2347 (2006).
  • Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med.347(23), 1825–1833 (2002).
  • Corley SD, Epstein AE, DiMarco JP et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Circulation109(12), 1509–1513 (2004).
  • Kaufman ES, Zimmermann PA, Wang T et al; Atrial Fibrillation Follow-up Investigation of Rhythm Management investigators. Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis. J. Am. Coll. Cardiol.44(6), 1276–1282 (2004).
  • Steinberg JS, Sadaniantz A, Kron J et al. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation109(16), 1973–1980 (2004).
  • Ren JF, Marchlinski FE, Callans DJ, Zado ES. Intracardiac Doppler echocardiographic quantification of pulmonary vein flow velocity: an effective technique for monitoring pulmonary vein ostia narrowing during focal atrial fibrillation ablation. J. Cardiovasc. Electrophysiol.13(11), 1076–1081 (2002).
  • Saad EB, Rossillo A, Saad CP et al. Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy. Circulation108(25), 3102–3107 (2003).
  • Bunch TJ, Asirvatham SJ, Friedman PA et al. Outcomes after cardiac perforation during radiofrequency ablation of the atrium. J. Cardiovasc. Electrophysiol.16(11), 1172–1179 (2005).

Websites

  • Definition of ‘first line’ www.cdc.gov/cancer/lung/glossary.htm
  • A typical university hospital website advertising a ‘cure’ for atrial fibrillation www.pennhealth.com/phys_forum/pto/mar_apr03/atrial.html
  • A university hospital website www.clevelandclinic.org/heartcenter/pub/history/future/afib.asp?firstCat=56&secondCat=57&thirdCat=492

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.